Related Experiment Video

Updated: Jun 12, 2026

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography
07:11

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography

Published on: October 28, 2020

The left ventricular outflow in hypertrophic cardiomyopathy: from structure to function

Magdi H Yacoub1, Ismail El-Hamamsy, Karim Said

  • 1Harefield Heart Science Center, Harefield Hospital, London, UK. m.yacoub@imperial.ac.uk

Journal of Cardiovascular Translational Research
|June 19, 2010
PubMed

Insights

Left ventricular outflow tract obstruction (LVOTO) in hypertrophic cardiomyopathy (HCM) stems from complex LVOT functions. Understanding these integrated functions is key to developing effective treatments for HCM patients.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Human Physiology

Background:

  • Left ventricular outflow tract obstruction (LVOTO) is a hallmark of hypertrophic cardiomyopathy (HCM).
  • The precise causes and optimal treatments for LVOTO in HCM remain subjects of ongoing debate.
  • A deeper understanding of the left ventricular outflow tract's (LVOT) structure and function is crucial.

Purpose of the Study:

  • To review the integrated functions of the LVOT in health and disease.
  • To elucidate the structural and functional relationships within the LVOT, focusing on its component parts.
  • To provide essential knowledge for developing tailored restorative techniques for HCM.

Main Methods:

  • Literature review of existing research on LVOT structure, function, and role in HCM.
  • Analysis of the biological properties and design characteristics of LVOT components.
  • Synthesis of information to understand the pathophysiology of LVOTO in HCM.

Main Results:

  • The LVOT performs sophisticated, vital functions mediated by its specific structural and biological properties.
  • Dysregulation of these integrated LVOT functions is implicated in the development of obstruction and other abnormalities in HCM.
  • Key component parts of the LVOT play critical roles in the manifestation of HCM.

Conclusions:

  • A comprehensive understanding of LVOT integrated functions and component roles is essential for advancing HCM treatment.
  • This knowledge facilitates the evolution of targeted therapeutic strategies for managing LVOTO in hypertrophic cardiomyopathy.
  • Future treatment approaches for HCM should consider the intricate functional dynamics of the LVOT.

More Related Videos

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...